Uncategorized
-
Ohi Selected as 2017 Chancellor Faculty Fellow
Twelve outstanding faculty members from across the university have been named to the 2017 class of Chancellor Faculty Fellows. The class comprises highly accomplished, recently tenured faculty from the social sciences, life and physical sciences, clinical sciences and humanities, as well as law, mathematics and engineering. Melanie Ohi is an associate professor… Read MoreFeb. 6, 2017
-
Hasty named to new VUSM Basic Sciences role
Alyssa Hasty, Ph.D., professor of Molecular Physiology and Biophysics, has been named Associate Dean for Faculty Development for Basic Sciences at Vanderbilt University School of Medicine. Hasty has devoted much of her career to mentoring and encouraging students and junior faculty members. She was one of the founding members and… Read MoreFeb. 3, 2017
-
Gene mutation discovery may hold autism clues: study
Researchers at Vanderbilt have identified what may be a genetic “smoking gun” for autism spectrum disorder (ASD) — a mutation in the gene for the critical neuronal protein CaMKII. While no single mutation can explain the immensely complicated picture presented by ASD, this study is the first to link a… Read MoreFeb. 3, 2017
-
Casagrande recalled as neuroscience pillar, supportive mentor
Vivien Casagrande, Ph.D., a neuroscientist and professor at Vanderbilt University School of Medicine noted for her contributions to the visual sciences, died peacefully at her home on Saturday, Jan. 21, surrounded by her husband, James Andrew “Mac” McKanna, and sons James and Paul McKanna. She was 74. Known internationally for… Read MoreJan. 26, 2017
-
Lindsley’s drug discovery efforts land ASPET Award
Craig Lindsley, Ph.D., a leader of Vanderbilt University School of Medicine’s groundbreaking drug discovery program, is the 2017 recipient of the Pharmacia-ASPET Award in Experimental Therapeutics from the American Society for Pharmacology and Experimental Therapeutics (ASPET). In a news release, ASPET said Lindsley was honored for “his pioneering use of technology-enabled synthesis,… Read MoreJan. 13, 2017
-
Boosting the Immune System to Fight Breast Cancer
Despite major strides in the early detection and treatment of breast cancer, metastatic disease remains a therapeutic challenge, resulting in over 40,000 deaths per year in the United States. Most breast cancers are the result of genetic mutations that lead to abnormal growth and invasive behavior of the tumor cells. Read MoreJan. 4, 2017
-
Sensing the Cellular Environment Through Integrins
Integrins are integral membrane proteins found on nearly every cell in multicellular animals. They provide the means by which cells interact with components of the extracellular matrix (ECM). In humans, integrins are heterodimers composed of one of 18 alpha subunits and one of 8 beta subunits, with 24 combinations found… Read MoreJan. 4, 2017
-
Unlocking the Mysteries of a Deadly Form of Lung Cancer
Small cell lung cancer (SCLC) is a highly aggressive, particularly deadly form of cancer noted for its early metastasis and resistance to therapy. One explanation for these traits is that SCLC is usually composed of heterogeneous cell populations, most often including cells with neuroendocrine (NE) traits and those with mesenchymal-like… Read MoreJan. 4, 2017
-
Investigational new drug for Alzheimer’s scheduled for first study in humans
Vanderbilt University scientists, led by P. Jeffrey Conn, Ph.D., Lee E. Limbird Professor of Pharmacology in the Vanderbilt University School of Medicine and director of the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD), have received notification from the U.S. Food and Drug Administration (FDA) that testing in humans may proceed for an investigational new… Read MoreDec. 28, 2016
-
Blind wins Tabor award for work on nuclear lipids
In August, Raymond Blind of Vanderbilt University won the Journal of Biological Chemistry/Herb Tabor Young Investigator Award at the 2016 Phospholipid Signaling in Cancer, Neurodegeneration and Cardiovascular Disease Conference in Steamboat, Colorado. Blind, who has demonstrated that lipid-signaling enzymes can activate genes, received the award from JBC Associate Editor George M. Carman from Rutgers University. Read MoreDec. 20, 2016